Similar articles for PMID: 16368270

Year	Number of Results
1957	1
1959	1
1970	1
1977	1
1981	1
1995	1
1996	1
1998	1
1999	2
2000	7
2001	6
2002	8
2003	12
2004	20
2005	15
2006	24
2007	15
2008	21
2009	17
2010	15
2011	18
2012	13
2013	14
2014	11
2015	16
2016	8
2017	9
2018	6
2019	6
2020	3
2021	4
2022	3
2023	1
2024	0

1

A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients.

Ayyoub M, Souleimanian NE, Godefroy E, Scotto L, Hesdorffer CS, Old LJ, Valmori D. Ayyoub M, et al. Clin Immunol. 2006 Feb-Mar;118(2-3):188-94. doi: 10.1016/j.clim.2005.10.002. Epub 2005 Dec 20. Clin Immunol. 2006. PMID: 16368270

2

Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer-free individuals.

Valmori D, Souleimanian NE, Hesdorffer CS, Old LJ, Ayyoub M. Valmori D, et al. Clin Immunol. 2005 Nov;117(2):161-7. doi: 10.1016/j.clim.2005.07.004. Epub 2005 Aug 15. Clin Immunol. 2005. PMID: 16103015

3

Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.

Bioley G, Dousset C, Yeh A, Dupont B, Bhardwaj N, Mears G, Old LJ, Ayyoub M, Valmori D. Bioley G, et al. Clin Cancer Res. 2009 Jul 1;15(13):4467-74. doi: 10.1158/1078-0432.CCR-09-0582. Epub 2009 Jun 16. Clin Cancer Res. 2009. PMID: 19531622

4

Vaccination with a recombinant protein encoding the tumor-specific antigen NY-ESO-1 elicits an A2/157-165-specific CTL repertoire structurally distinct and of reduced tumor reactivity than that elicited by spontaneous immune responses to NY-ESO-1-expressing Tumors.

Bioley G, Guillaume P, Luescher I, Bhardwaj N, Mears G, Old L, Valmori D, Ayyoub M. Bioley G, et al. J Immunother. 2009 Feb-Mar;32(2):161-8. doi: 10.1097/CJI.0b013e31819302f6. J Immunother. 2009. PMID: 19238015

5

Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo.

Garcia Casado J, Janda J, Wei J, Chapatte L, Colombetti S, Alves P, Ritter G, Ayyoub M, Valmori D, Chen W, Lévy F. Garcia Casado J, et al. Eur J Immunol. 2008 Jul;38(7):1867-76. doi: 10.1002/eji.200737923. Eur J Immunol. 2008. PMID: 18546142 Free article.

6

Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.

Sharma P, Bajorin DF, Jungbluth AA, Herr H, Old LJ, Gnjatic S. Sharma P, et al. J Immunother. 2008 Nov-Dec;31(9):849-57. doi: 10.1097/CJI.0b013e3181891574. J Immunother. 2008. PMID: 18833002

7

Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma.

Korangy F, Ormandy LA, Bleck JS, Klempnauer J, Wilkens L, Manns MP, Greten TF. Korangy F, et al. Clin Cancer Res. 2004 Jul 1;10(13):4332-41. doi: 10.1158/1078-0432.CCR-04-0181. Clin Cancer Res. 2004. PMID: 15240519

8

Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.

Tsuji K, Hamada T, Uenaka A, Wada H, Sato E, Isobe M, Asagoe K, Yamasaki O, Shiku H, Ritter G, Murphy R, Hoffman EW, Old LJ, Nakayama E, Iwatsuki K. Tsuji K, et al. Cancer Immunol Immunother. 2008 Oct;57(10):1429-37. doi: 10.1007/s00262-008-0478-5. Epub 2008 Mar 1. Cancer Immunol Immunother. 2008. PMID: 18311489

9

Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.

Nicholaou T, Ebert LM, Davis ID, McArthur GA, Jackson H, Dimopoulos N, Tan B, Maraskovsky E, Miloradovic L, Hopkins W, Pan L, Venhaus R, Hoffman EW, Chen W, Cebon J. Nicholaou T, et al. Clin Cancer Res. 2009 Mar 15;15(6):2166-73. doi: 10.1158/1078-0432.CCR-08-2484. Epub 2009 Mar 10. Clin Cancer Res. 2009. PMID: 19276262 Clinical Trial.

10

Antigen-specific immunity in neuroblastoma patients: antibody and T-cell recognition of NY-ESO-1 tumor antigen.

Rodolfo M, Luksch R, Stockert E, Chen YT, Collini P, Ranzani T, Lombardo C, Dalerba P, Rivoltini L, Arienti F, Fossati-Bellani F, Old LJ, Parmiani G, Castelli C. Rodolfo M, et al. Cancer Res. 2003 Oct 15;63(20):6948-55. Cancer Res. 2003. PMID: 14583496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

253 results

Results by year